Last Updated:
Hexagon Nutrition IPO GMP: Unlisted shares of Hexagon Nutrition Ltd trade at Rs 51.5 apiece in the grey market, which is a 14.4% premium over the upper IPO price of Rs 45.
Hexagon Nutrition IPO.
Hexagon Nutrition IPO GMP: The initial public offering of Hexagon Nutrition Ltd has been closed today, June 9. The price band of the IPO was fixed in the range of Rs 42 to Rs 45 per share. On the final day of bidding on Tuesday, the Rs 138.87-crore IPO received a 127.07 times subscription, garnering bids for 2,92,81,25,148 shares as against the 2,16,02,008 shares on offer.
Its retail category has received a 27.08x subscription so far, while the qualified institutional buyer (QIB) quota has received a muted 270.46x subscription. The non-institutional investor (NII) category received a 172.35x subscription.
The company, which was founded in 1993, started as a micronutrient formulations business and later diversified into branded nutrition products. Its portfolio includes brands such as Pentasure, Obesigo and Pediagold across health, wellness and clinical nutrition segments. Hexagon Nutrition has a presence across 75 countries and offers a wide range of products, including micronutrient premixes, therapeutic nutrition, clinical nutrition, wellness products and fortified foods.
The IPO was opened for subscription on June 5. The stock will be listed on both the BSE and the NSE on June 12, 2026.
The basis of allotment for the Hexagon Nutrition IPO will likely be finalised on June 10. Once finalised, investors can check their allotment status on the websites of the BSE and the NSE, as well as Kfin Technologies.
Hexagon Nutrition IPO GMP Today
According to market observers, unlisted shares of Hexagon Nutrition Ltd were trading at Rs 51.5 apiece in the grey market, which is a 14.44 per cent premium over the upper IPO price of Rs 45. It indicates decent listing gains for investors on Friday, June 12.
The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Hexagon Nutrition IPO: Should You Apply?
Brokerage firm SBI Securities has assigned a ‘subscribe’ rating to the Hexagon Nutrition IPO for investors with a long-term investment perspective. The brokerage believes the company is well placed to benefit from growing demand in the nutrition and wellness sector, driven by rising health consciousness and increasing consumption of fortified food products.
SBI Securities highlighted Hexagon Nutrition’s diversified business model and its strong presence in the premix formulations segment, supported by operations across multiple international markets. It also pointed to the company’s improving financial performance, noting that revenue, EBITDA and profit after tax recorded CAGR growth of 8%, 35.1% and 104.6%, respectively, between FY23 and FY25.
At the upper end of the price band of ₹45 per share, the IPO is valued at a price-to-earnings (P/E) multiple of 15.3 times based on annualised earnings for the first nine months of FY26. Based on its growth prospects and valuation, SBI Securities has recommended subscribing to the issue for long-term gains.
The brokerage, however, cautioned investors about certain risks, including the company’s significant reliance on the premix formulations business, concentration among key customers, fluctuations in raw material prices, and regulatory challenges associated with the food and nutrition industry.
About the Author
Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to personal finance, markets, economy and companies. Having over a decade of experience in financial journalis…Read More
Read More
Source link
[ad_3]
